Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
about
Glial Modulation by N-acylethanolamides in Brain Injury and NeurodegenerationDoes neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytesTargeting neuroinflammation in Alzheimer's diseaseThe Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s DiseaseThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease.An update on PPAR activation by cannabinoids.Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.An Animal Model of Alzheimer Disease Based on the Intrahippocampal Injection of Amyloid β-Peptide (1-42).Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain.Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.
P2860
Q26747533-376C83E5-1F53-4BFE-BDB8-41918C61351FQ26797413-51D68ADD-95E6-42D3-9B55-11A7548BBC8EQ28078474-AA9E4369-5D4A-4494-B27E-FC4D74385E03Q28468424-E9F90DC2-7470-4E0B-AFF5-F8BB7F21204DQ31122398-64F250FC-92F1-4F1F-9CE4-1DB5B2B121F8Q35564173-9C813FB2-5EF6-461C-9D5E-21D1169E1737Q38808034-0CDEDF05-880F-4858-B695-C66CA701D90CQ42150000-81390789-80CC-44FA-B6D8-A38DEF6B8388Q47623854-E7E752A4-2DBA-4EE2-840F-7828DA265407Q47925078-A258D6B9-2402-492E-B77C-0A152E0BD96BQ47962439-C7B4AB0E-197A-4035-8F71-C4A65505B8BDQ48139053-A9716503-80D4-4719-B377-F7CDBAB8F247Q52584461-1A93E70C-4C72-49D6-9045-CECB4F511BFFQ52632555-5538A386-2613-4C45-A7F6-DB618B91C971
P2860
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@en
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@nl
type
label
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@en
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@nl
prefLabel
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@en
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@nl
P2093
P2860
P50
P356
P1476
Palmitoylethanolamide controls ...... model of Alzheimer's disease.
@en
P2093
P2860
P2888
P356
10.1038/CDDIS.2014.376
P50
P577
2014-09-11T00:00:00Z
P5875
P6179
1039338548